The association between psoriasis and dyslipidaemia: a systematic review.
about
Dyslipidemia in Dermatological DisordersAtherosclerosis in psoriatic disease: latest evidence and clinical implicationsPsoriasis and comorbid diseases: Epidemiology.Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US womenPsoriasis and comorbidities: links and risks.LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.Psoriasis and dyslipidemia.Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures.Psoriasis and cardiovascular risk assessment in primary careEffect of psoriasis severity on hypertension control: a population-based study in the United KingdomPresence of selected metabolic syndrome components in patients with psoriasis vulgaris.Psoriasis comorbidities: complications and benefits of immunobiological treatmentEpidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male miceEndothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference.Increased risk of stroke in contact dermatitis patients: A nationwide population-based retrospective cohort study.Psoriasis and smoking: a systematic review and meta-analysis.Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.Psoriasis-associated vascular disease: the role of HDL.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).The prevalence of cardiovascular diseases risk factors associated with psoriasis in Saudi Arabia.Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis.Risk of sudden sensorineural hearing loss in patients with psoriasis: a retrospective cohort study.Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris.Subclinical systemic and vascular inflammation detected by (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with mild psoriasis.Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study.
P2860
Q26771723-F50FFFE6-19BC-4BDB-8504-69F966C81A8CQ26783501-D0F9F0F6-E476-421C-9091-FAC6D3AB4027Q30235889-8203BEF7-F855-40D5-9CAF-0BA50771062CQ30250110-DC94DA7D-F93D-4F91-8863-66B2E45035AFQ33848992-06EC9254-D098-4894-9957-5B2E3AD922B5Q34418506-B0A5E1F5-46A4-4465-B7D9-29AB78A3423EQ34855603-A9B3465F-C8C9-470A-BAF1-336C3144EBD5Q34981499-77AD3129-2A66-4ACE-98F0-F1B06775FAA4Q35045850-47620941-6025-42D3-AA95-5F0E7FF739C6Q35263254-A3EB092B-A87F-4246-925A-618CD26676BAQ35470124-FBAD240B-26F5-4630-9B59-E93D972CAF88Q35966928-AF5E1CDA-B3AB-4F76-A023-2D35F5BCCBA4Q36506489-D141F001-56D8-4224-B84E-E3287570559BQ36946167-FCE4948E-4240-4D7E-A3BA-1C81AF1D3A86Q37540440-73FFAC60-38B0-464A-A4AF-652D101818F3Q37629138-B6D327D5-5DA7-40D8-B9C4-92A1D5B4FBF6Q37648544-EFA1D113-B54B-4145-A6F7-C263C8163871Q37690746-667E60FD-7487-48C4-A5EB-E707E7133CF0Q37696815-300AF001-477E-48D5-87E0-332B44A369CFQ38151781-D8EC1364-FFA0-4B92-9A2A-5D3053A8A66FQ38194199-78473CE5-D43D-4C92-A105-27CA7AB41199Q38749538-3DAB85F8-D48F-4CEE-8F87-0C016243A11FQ38970218-9A7EE673-5F55-4489-BAE5-77930B8ABB58Q41108229-019F77E6-AF94-4802-9B56-CE48882B7618Q46180528-7EBC9FCC-C1A0-4037-AFD1-925A7E29C859Q47218445-9566F584-ACA3-41E3-8F3D-141A38CCACBAQ48239956-A4B2496A-DA6C-4EDC-9158-CF32B869EB28Q49404216-BA3A9CDA-0769-4E1A-BF6E-936A66028D1CQ50333986-D9D1034A-B2B0-4A3F-B4E2-43F450647FC3Q50353072-3A0C782B-7826-4BF3-8C66-9B1961C7A6A7Q51025899-2B04CFD1-4E04-4389-82A6-E52E6828FD02Q53019536-B1B5C31A-366C-4CB6-BFD4-0C886C59B9ECQ53096105-B5E0E8BB-EC0F-4ED5-953C-E63897BA07E8
P2860
The association between psoriasis and dyslipidaemia: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The association between psoriasis and dyslipidaemia: a systematic review.
@en
type
label
The association between psoriasis and dyslipidaemia: a systematic review.
@en
prefLabel
The association between psoriasis and dyslipidaemia: a systematic review.
@en
P2093
P2860
P356
P1476
The association between psoriasis and dyslipidaemia: a systematic review.
@en
P2093
A W Armstrong
C T Harskamp
E J Armstrong
P2860
P304
P356
10.1111/BJD.12101
P407
P577
2013-01-18T00:00:00Z